Shares in the French biotech firm rose 25.2 percent after sealing joint venture with China PET powerhouse, Wankai.
The Call It What You Want author joins Cosmo Reads for her much-awaited sequel about a romance writer’s personal quest for ...
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today announced new biomarker data identifying a molecular signature that predicts sensitivity to Sapu003, the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results